Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: An expanded dataset Meeting Abstract
| Authors: | Perreault, S.; Doz, F.; Drilon, A.; Geoerger, B.; Boni, V.; Chisholm, J.; Dubois, S. G.; Grilley-Olson, J. E.; Hong, D. S.; Italiano, A.; Kang, H.; Nysom, K.; Øra, I.; Owens, C.; Schulte, J. H.; Tahara, M.; Ziegler, D.; Ellezam, B.; Reeves, J. A.; Fellous, M.; De La Cuesta, E.; Laetsch, T. W.; van Tilburg, C. M. |
| Abstract Title: | Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: An expanded dataset |
| Meeting Title: | 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Nov 19-21 |
| Meeting Location: | Virtual |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | ii58 |
| Language: | English |
| ACCESSION: | WOS:000590061300234 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noaa215.233 |
| Notes: | Meeting Abstract: CTNI-67 -- Source: Wos |
